Naproxen Ec Aurobindo (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By decreasing prostaglandin production, naproxen reduces the inflammatory response, diminishes pain signaling, and helps control fever.

The appropriate dose of naproxen is determined by a qualified prescriber based on the patient’s condition, age, weight, and overall health status. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

Naproxen is generally avoided during the third trimester of pregnancy because of potential risks to the fetus. Use during earlier stages should only be considered if the potential benefit outweighs the risk and after consultation with a healthcare provider. Limited data are available for breastfeeding, so a prescriber should evaluate safety before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Naproxen Ec Aurobindo. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of action. Naproxen has a longer half‑life, often allowing twice‑daily dosing, whereas ibuprofen typically requires three‑ or four‑times‑daily dosing. Individual response, safety profile, and specific clinical considerations guide the choice between the two agents.

Naproxen should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and store away from direct sunlight or heat sources. Ensure the container is tightly closed to maintain stability.

Naproxen is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should follow the prescriber’s instructions regarding timing and any specific administration guidelines.

The most serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and severe skin reactions like Stevens‑Johnson syndrome. Patients with a history of ulcers, heart disease, or renal impairment should be monitored closely, and any signs of serious adverse effects require immediate medical attention.

Naproxen should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal bleeding, severe heart failure, or in the third trimester of pregnancy. It is also contraindicated in patients taking certain anticoagulants or those with uncontrolled hypertension unless directed by a physician.